Tongkat Ali for Male Infertility

Verdict: Weak, preliminary evidence for male fertility

Tongkat ali (Eurycoma longifolia) shows promising but weak, preliminary evidence for male infertility: small early trials report improvements in sperm parameters, but no adequately controlled study has demonstrated higher pregnancy or live-birth rates, and real safety concerns exist. It should not be relied on as a fertility treatment.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This intervention earns a Weak (Grade C) rating because the human evidence is small, heterogeneous, and silent on the outcomes that matter most. The largest fertility trial (PMID 20348942, n=350) was open-label with no placebo arm and only 75 men completing a cycle, so its reported gains in all semen parameters and 14.7% spontaneous-pregnancy figure cannot be attributed to the extract. The one true double-blind RCT (PMID 23243445, n=109) was powered for quality-of-life endpoints and reported +44.4% sperm motility and +18.2% semen volume only as secondary within-group changes, with no pregnancy outcomes.

Higher-tier syntheses do not close the gap. A narrative systematic review (PMID 28259255) found most included studies favorable but pooled no effect sizes, and the only meta-analysis (PMID 36013514) pools serum testosterone (SMD 1.352, 95% CI 0.565-2.138), not fertility or semen quality. An in-vitro study (PMID 22332826) found the extract neutral on sperm at therapeutic concentrations. No clinic or guideline body (Mayo, Cleveland, Harvard, NIH ODS, AUA/ASRM) endorses it by name for infertility.

Safety and regulatory signals also weigh on the grade. The US FDA/OPSS notes products contaminated with heavy metals such as lead and mercury and that human safety is not fully established; the EU EFSA refused a novel-food application, concluding the root extract has potential to induce DNA damage. The bottom line: tongkat ali may modestly affect semen markers, but it is unproven for achieving pregnancy and carries contamination and genotoxicity concerns.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.47
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
82%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.472
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Eurycoma longifolia Jack in managing idiopathic male infertility
PMID: 20348942 2010 RCT (open-label) n = 350
Finding: Among the 75 men who completed one full 3-month cycle, all semen parameters (volume, concentration, motility, morphology) improved significantly from baseline; 11 spontaneous pregnancies (14.7%) were reported. No placebo arm, so improvement cannot be attributed to the extract with confidence.
🟠 Limited quality Effect size: Significant improvement reported for all four semen parameters; absolute effect sizes/CIs not stated in abstract
View on PubMed
Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men
PMID: 23243445 2012 RCT (double-blind) n = 109
Finding: Treatment group showed sperm motility improvement of 44.4% and semen volume increase of 18.2% by end of treatment, alongside improved erectile function and physical functioning. Semen parameters were secondary endpoints; the trial was powered for quality-of-life outcomes, not fertility endpoints, and no pregnancy outcomes were reported.
Effect size: Sperm motility +44.4%, semen volume +18.2% (within-group relative change); between-group statistical comparison for semen endpoints not clearly reported in abstract
View on PubMed
Eurycoma Longifolia as a potential adoptogen of male sexual health: a systematic review on clinical studies
PMID: 28259255 2017 統合分析
Finding: Of 11 included clinical studies, 7 showed a remarkable association between E. longifolia use and efficacy for male sexual disorders while 4 showed limited effects; the review reported improvements in semen volume, sperm concentration, normal morphology and motility in the infertility-focused studies. The review is narrative, includes heterogeneous designs (some uncontrolled), and does not pool effect sizes.
🟠 Limited quality Effect size: Not pooled; qualitative direction favorable
View on PubMed
Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials
PMID: 36013514 2022 統合分析
Finding: Meta-analysis found a significant increase in total testosterone (SMD 1.352, 95% CI 0.565 to 2.138, p=0.001). Semen quality and spontaneous pregnancy improvements were noted only narratively from individual studies, not pooled. Authors concluded more research is required before clinical use; this MA addresses testosterone, not male infertility as a pooled endpoint.
Effect size: Total testosterone SMD 1.352 (95% CI 0.565-2.138); no pooled semen/fertility effect size
View on PubMed
Effect of Eurycoma longifolia Jack (Tongkat ali) extract on human spermatozoa in vitro
PMID: 22332826 2012 In vitro n = 40
Finding: TA extract had no deleterious effects on sperm function at therapeutically relevant concentrations (<2.5 ug/ml) and dose-dependently increased acrosome-reacted spermatozoa; at very high concentrations TA may be harmful in vitro. This is a mechanistic in-vitro study, not a clinical fertility outcome study.
🟠 Limited quality Government Effect size: Dose-dependent increase in acrosome reaction (p<0.0001) at high doses; neutral at therapeutic doses
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Products containing tongkat ali have been reported to be contaminated with heavy metals (such as lead and mercury) source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Against
東革阿里(Eurycoma longifolia)業經衛生福利部食品藥物管理署評估,不得供作食品原料,如供食品用途,則涉及違反食品安全衛生管理法第15條第1項第9款規定,從未於國內供作飲食且未經證明為無害人體健康。 source↗
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-male-infertility-INT-tongkat-ali-001 繁體中文版 →